β2-adrenergic receptor agonists

Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C564S305000, C564S336000, C564S355000, C568S700000, C568S704000

Reexamination Certificate

active

06916961

ABSTRACT:
Disclosed are multibinding compounds which are β2 adrenergic receptor agonists and are useful in the treatment and prevention of respiratory diseases such as asthma, bronchitis. They are also useful in the treatment of nervous system injury and premature labor.

REFERENCES:
patent: 3875233 (1975-04-01), Bastian et al.
patent: 4021485 (1977-05-01), Schromm et al.
patent: 6268533 (2001-07-01), Gao et al.
patent: 1158082 (1963-11-01), None
patent: 0196849 (1986-10-01), None
patent: 0233686 (1987-08-01), None
patent: 1394542 (1975-05-01), None
patent: 1040724 (1996-09-01), None
Japanese Patent publication JP 10152460 A, Jun. 9, 1998 (English translation of abstract provided).
Chem. Abstract 75:457-458, 35405m Wismayr et al. (1971).
Yokoi et al., “The Development of a Radioimmunoassay for Formoterol,” Life Sci. 33(17):1665-1672 (1983).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

β2-adrenergic receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with β2-adrenergic receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and β2-adrenergic receptor agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3378533

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.